Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Paul Friedman


  • Director at Cerulean Pharma Inc. (CERU), 2016-10-20
  • Chief Executive Officer at Madrigal Pharmaceuticals Inc. (MDGL), 2016-08-23
  • Director at Verastem Inc. (VSTM), 2016-06-16
  • Director at Incyte Corp (INCY), 2016-05-31
  • Director at Auxilium Pharmaceuticals Inc (AUXL), 2015-01-30
  • Director at Durata Therapeutics Inc. (DRTX), 2014-11-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
VSTM $8.31 3,000 Director 3,000 2014-12-24 Filing
INCY $10.43 5,697 Officer, Director 264,565 2010-07-01 Filing
INCY $10.42 4,303 Officer, Director 258,868 2010-07-01 Filing
INCY $2.10 9,400 Officer, Director 254,565 2009-03-09 Filing
INCY $2.10 10,600 Officer, Director 245,165 2009-03-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
INCY $115.12 38,868 Director 297,518 2015-11-18 Filing
INCY $115.42 86,132 Director 336,386 2015-11-18 Filing
INCY $111.37 50,000 Director 297,518 2015-11-17 Filing
INCY $112.53 42,948 Director 347,518 2015-11-17 Filing
INCY $112.71 7,052 Director 390,466 2015-11-17 Filing

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!